Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Pozycja w akcjach #199
GSK plc, together with its subsidiaries, engages in the creation, discovery,... GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Cena akcji
$51.99
Kapitalizacja rynkowa
$104.42B
Zmiana (1 dzień)
0.29%
Zmiana (1 rok)
32.49%
Kraj
GB
Handel GSK plc (GSK)

Kategoria

EPS dla GSK plc (GSK)
EPS na dzień December 2025 TTM: $3.82
Według najnowszych raportów finansowych i ceny akcji firmy GSK plc, obecny EPS (TTM) wynosi $3.82. Na koniec roku 2024 firma miała EPS w wysokości $1.58, spadek w porównaniu do do EPS z roku 2023, który wynosił $3.11.
Historia EPS dla GSK plc od 2000 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
2026 (TTM) $3.82 2.94%
2025 $3.71 134.74%
2024 $1.58 -49.10%
2023 $3.11 5.22%
2022 $2.95 -20.32%
2021 $3.70 -5.92%
2020 $3.94 26.89%
2019 $3.10 32.40%
2018 $2.34 122.33%
2017 $1.05 77.94%
2016 $0.59 -90.78%
2015 $6.42 186.38%
2014 $2.24 -51.96%
2013 $4.67 25.18%
2012 $3.73 -8.24%
2011 $4.07 226.52%
2010 $1.25 -71.71%
2009 $4.40 35.82%
2008 $3.24 -31.08%
2007 $4.70 0.76%
2006 $4.67 31.64%
2005 $3.55 8.50%
2004 $3.27 -5.77%
2003 $3.47 29.66%
2002 $2.67 45.99%
2001 $1.83 -27.83%
2000 $2.54 0.00%
EPS dla podobnych firm lub konkurentów
Firma EPS Różnica w EPS Kraj
$23.00 502.24%
US
$13.20 245.63%
GB
$11.10 190.64%
US
$2.37 -37.94%
US
$7.20 88.53%
CH